Jonathan Krinsky, BTIG chief market technician, joins CNBC's Closing Bell to discuss market outlooks.

Fintel reports that on November 19, 2024, BTIG upgraded their outlook for Aclaris Therapeutics (NasdaqGS:ACRS) from Neutral ...

BTIG analyst Marvin Fong raised the firm’s price target on RealReal (REAL) to $5.50 from $4 and keeps a Buy rating on the shares. The firm ...

Aclaris (ACRS) soared 60% Tuesday, the day after the company announced it was licensing two drug candidates, prompting ...

BTIG upgraded Aclaris Therapeutics (ACRS) to Buy from Neutral with an $8 price target In a “transformative transaction,” Aclaris has acquired ...

“Donald Trump cares about independent validators. And the biggest independent validator of his success is the market. It’s a ...

Plug Power downgraded at BTIG Research, citing need for more product sales to boost margins in the hydrogen market.

Donald Trump has been somewhat cagey about his economic plans — especially tariffs — since voters elected him president. That is raising the stakes in a drawn-out contest to become his treasury ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its Digital Health Forum will take place on Monday, November 25, 2024. The event will be hosted by David Larsen, CFA, BTIG Healthcare IT and ...

On Monday, DoorDash Inc (DASH) stock saw a modest uptick, ending the day at $172.73 which represents a slight increase of $3.30 or 1.95% from the prior close of $169.43. The stock opened at $169.78 ...

On Monday, Fiserv Inc (FI) stock saw a modest uptick, ending the day at $212.74 which represents a slight increase of $1.82 or 0.86% from the prior close of $210.92. The stock opened at $211.01 and ...

Yet there is another force that could deter Trump from some of his most extreme instincts: the $50 trillion US stock market.